Analysis of blood exosomes from septic patients with and without delirium

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00018870

Enrollment

Registered

2019-11-27

Start date

2019-12-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delir / delirium, septic encephalopathy

Interventions

Group 1: Blood draw from intensive patients with sepsis or septic shock without delir - onset < 24h

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - informed content - Age < 18 years - Delirium on septic patients

Exclusion criteria

Exclusion criteria: - Age: < 18 years - no informed content - Transfer of patient to another station < 72h - palliative care or forthcoming death - second visit on ICU after the previous study inclusion - application of immunsuppressive therapy (cortison, ciclosporin, tarolismus, MMF)

Design outcomes

Primary

Measure	Time frame
Exosomes in the blood Primary end point: blood draw for exosome Analysis at time point 'zero' and 48 h thereafter	—

Secondary

Measure	Time frame
hospital discharge	—

Countries

Germany

Contacts

Public ContactKonstanze Plaschke

Universitätsklinikum Heidelberg, Klinik für Anästhesiologie

konstanze.plaschke@med.uni-heidelberg.de06221-566451

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026